Cargando…

Differentiating Multiple Myeloma and Osteolytic Bone Metastases on Contrast-Enhanced Computed Tomography Scans: The Feasibility of Radiomics Analysis

Osteolytic lesions can be seen in both multiple myeloma (MM), and osteolytic bone metastasis on computed tomography (CT) scans. We sought to assess the feasibility of a CT-based radiomics model to distinguish MM from metastasis. This study retrospectively included patients with pre-treatment thoraci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Seungeun, Lee, So-Yeon, Kim, Sanghee, Huh, Yeon-Jung, Lee, Jooyeon, Lee, Ko-Eun, Jung, Joon-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955828/ https://www.ncbi.nlm.nih.gov/pubmed/36832243 http://dx.doi.org/10.3390/diagnostics13040755

Ejemplares similares

Detecting Multiple Myeloma Infiltration of the Bone Marrow on CT Scans in Patients with Osteopenia: Feasibility of Radiomics Analysis
por: Park, Hyerim, et al.
Publicado: (2022)

Ensemble learning-based radiomics with multi-sequence magnetic resonance imaging for benign and malignant soft tissue tumor differentiation
por: Lee, Seungeun, et al.
Publicado: (2023)

Two Cases of Primary Osteolytic Intraosseous Meningioma of the Skull Metastasizing to Whole Skull and the Spine
por: Kim, Hyool, et al.
Publicado: (2012)

Prostate carcinoma presenting with diffuse osteolytic metastases and supraclavicular lymphadenopathy mimicking multiple myeloma
por: Idowu, Bukunmi Michael
Publicado: (2017)

Osteosclerotic & osteolytic lesions in multiple myeloma
por: Ram, Rapur, et al.
Publicado: (2014)

Sotatercept in patients with osteolytic lesions of multiple myeloma
por: Abdulkadyrov, Kudrat M, et al.
Publicado: (2014)

Osteolytic lesions: Multiple myeloma or prostate cancer?
por: Devaraj, Akshitha, et al.
Publicado: (2023)

Preventing osteolytic lesions and osteomyelitis in multiple myeloma
por: Dao, Aiken, et al.
Publicado: (2022)

Ra223 in Bone Metastases with Osteolytic Activity
por: Costa, Renato Patrizio, et al.
Publicado: (2018)

Osteocyte CIITA aggravates osteolytic bone lesions in myeloma
por: Liu, Huan, et al.
Publicado: (2022)

Diagnosis of Local Recurrence of Malignant Soft Tissue Tumors after Reconstructive Surgery on MRI
por: Song, Eun-Hee, et al.
Publicado: (2023)

Multiple myeloma presenting as a massive osteolytic lesion at the clivus
por: Sousa, Domingos, et al.
Publicado: (2020)

Differentiation of multiple myeloma and metastases: Use of axial diffusion-weighted MR imaging in addition to standard MR imaging at 3T
por: Park, Ga Eun, et al.
Publicado: (2018)

Prostate adenocarcinoma with osteolytic metastases: Case report and review of the literature
por: Rummel, Keaton, et al.
Publicado: (2021)

Circulating microRNAs Correlate with Multiple Myeloma and Skeletal Osteolytic Lesions
por: Moura, Sara Reis, et al.
Publicado: (2021)

Radiomics of diffusion-weighted MRI compared to conventional measurement of apparent diffusion-coefficient for differentiation between benign and malignant soft tissue tumors
por: Lee, Seung Eun, et al.
Publicado: (2021)

HDAC6-Selective Inhibitor Overcomes Bortezomib Resistance in Multiple Myeloma
por: Lee, Sang Wu, et al.
Publicado: (2021)

Assessing Osteolytic Lesion Size on Sequential CT Scans Is a Reliable Study Endpoint for Bone Remineralization in Newly Diagnosed Multiple Myeloma
por: Grunz, Jan-Peter, et al.
Publicado: (2023)

Hedgehog Signaling in Tumor Cells Facilitates Osteoblast-Enhanced Osteolytic Metastases
por: Das, Shamik, et al.
Publicado: (2012)

Radiomic Analysis of Positron-Emission Tomography and Computed Tomography Images to Differentiate between Multiple Myeloma and Skeletal Metastases
por: Mannam, Pallavi, et al.
Publicado: (2022)

Osteolytic Lesion of the Maxilla in an Undiagnosed Multiple Myeloma Patient Identified Incidentally by Cone Beam Computed Tomography
por: Ali, Sarah AlFarabi, et al.
Publicado: (2022)

Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
por: Ryoo, Seungeun, et al.
Publicado: (2023)

In vitro osteolytic activity of human myeloma plasma cells and the clinical evaluation of myeloma osteoclastic bone lesions.
por: Rossi, J. F., et al.
Publicado: (1984)

Characterizing Computed Tomography-Detected Arterial Hyperenhancing-Only Lesions in Patients at Risk of Hepatocellular Carcinoma: Can Non-Contrast Magnetic Resonance Imaging Be Used for Sequential Imaging?
por: Park, So Hyun, et al.
Publicado: (2020)

Idiopathic Hypertrophic Spinal Pachymeningitis with an Osteolytic Lesion
por: Jee, Tae Keun, et al.
Publicado: (2014)

Bone Mass Changes Following Percutaneous Radiofrequency Ablation, Osteoplasty, Reinforcement, and Internal Fixation of Periacetabular Osteolytic Metastases
por: Jiang, Will, et al.
Publicado: (2023)

An MRI-based radiomics nomogram for differentiating spinal metastases from multiple myeloma
por: Zhang, Shuai, et al.
Publicado: (2023)

A comparative study of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases
por: Zhang, Lin, et al.
Publicado: (2015)

Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone Metastases
por: McCarty, Mark F., et al.
Publicado: (2016)

Percutaneous cementoplasty for painful osteolytic distal femur metastases: a case report
por: Lei, Mingxing, et al.
Publicado: (2016)

Primary Osteolytic Intraosseous Atypical Meningioma with Soft Tissue and Dural Invasion: Report of a Case and Review of Literatures
por: Yun, Jung-Ho, et al.
Publicado: (2014)

Contrast-enhanced ultrasound for the diagnosis of acute pyelonephritis in pediatric patients with urinary tract infection: A feasibility study
por: Lee, Han Byeol, et al.
Publicado: (2023)

Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function
por: Choi, Bongkun, et al.
Publicado: (2014)

SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
por: Heusschen, Roy, et al.
Publicado: (2016)

Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling
por: Liu, Huan, et al.
Publicado: (2021)

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
por: Gai, Dongzheng, et al.
Publicado: (2022)

A radiomic biomarker for prognosis of resected colorectal cancer liver metastases generalizes across MRI contrast agents
por: Chen, Jianan, et al.
Publicado: (2023)

Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma
por: Song, Ga-Young, et al.
Publicado: (2019)

Contrast-enhanced Multi-detector CT Examination of Parotid Gland Tumors: Determination of the Most Helpful Scanning Delay for Predicting Histologic Subtypes
por: Kim, Tae-Yeon, et al.
Publicado: (2019)

Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone
por: Aldridge, S E, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_gcjcpjb9qcg68e12599j41jq2a